Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2022 Jan 12:S2213-2198(22)00003-4. doi: 10.1016/j.jaip.2021.12.031

Figure 2.

Figure 2

Diagnosis distribution associated with BST ≥ 11.5 ng/mL. Mastocytosis includes subjects with MCL, ISM, ASM, MMAS, and CM. Other myeloid neoplasms include 1 subject each with FIP1L1-PDGFRa associated CEL, MDS, and SM-PV. Eight subjects had two associated diagnoses (see text for full description of subjects).